SCHEDULE: Sio Capital Discloses 7.07% Stake in NeuroOne
Beneficial Ownership Disclosure
Sio Capital Management, LLC has disclosed a 7.07% beneficial ownership stake in NeuroOne Medical Technologies Corp, holding 3,523,663 common shares.
Summary
- Sio Capital Management, LLC (Sio) has filed a Schedule 13G, reporting beneficial ownership of 3,523,663 shares of NeuroOne Medical Technologies Corp's Common Stock.
- This ownership represents 7.07% of the issuer's outstanding common stock.
- The percentage is calculated based on 49,817,835 common shares outstanding as of May 9, 2025, as disclosed in NeuroOne's 10-Q filing on May 13, 2025.
- Sio Capital Management, LLC, a Delaware limited liability company, is a registered investment adviser and holds shared voting and shared dispositive power over all reported shares.
- The shares are held for the benefit of certain affiliated funds for which Sio acts as an investment adviser.
Sentiment
Score: 5
Explanation: A Schedule 13G filing is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the issuer's performance or outlook.
Positives
- The disclosure of a significant stake by an investment adviser like Sio Capital Management, LLC can be interpreted as a vote of confidence by an institutional investor in NeuroOne Medical Technologies Corp.
Future Outlook
NA
Industry Context
NA
Related Party Transactions
- Sio Capital Management, LLC acts as investment adviser to various affiliated funds that are record owners of the common stock.
- Sio GP, LLC acts as general partner to these clients and may be deemed a beneficial owner due to oversight of Sio's investment discretion.
- Both Sio Capital Management, LLC and Sio GP, LLC are controlled by Michael Castor, who may also be deemed to control voting and dispositive decisions over the shares.
Stakeholder Impact
- Shareholders are informed of a significant institutional investor's position in the company, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 2025-05-09 | Date as of which NeuroOne Medical Technologies Corp's common shares outstanding were reported. |
| 2025-05-13 | Date NeuroOne Medical Technologies Corp's 10-Q was disclosed, reporting common shares outstanding. |
| 2025-06-30 | Date of event which requires filing of this statement. |
| 2025-08-13 | Date of filing and certification by Sio Capital Management, LLC. |
Keywords
NeuroOne Medical Technologies, Sio Capital Management, Beneficial Ownership, SEC Filing, Schedule 13G, Investment Adviser, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.